跳转至内容
Merck
所有图片(1)

Key Documents

CBA042

Sigma-Aldrich

InnoZyme TACE Activity Kit

别名:

α-Secretase Activity Kit, TNF-α Converting Enzyme Activity Kit, ADAM17 Activity Kit, ADAM17 Activity Kit, α-Secretase Activity Kit, TNF-α Converting Enzyme Activity Kit

登录查看公司和协议定价


About This Item

分類程式碼代碼:
41116133
NACRES:
NA.84

用途

sufficient for 96 tests

品質等級

包裝

pkg of 1 96-well plate(s)

製造商/商標名

Calbiochem®

儲存條件

OK to freeze
avoid repeated freeze/thaw cycles
protect from light

assay range

standard curve range: 5-100 ng/mL
(as measured with purified recombinant human TACE)

輸入

sample type cells

檢測方法

fluorometric

運輸包裝

wet ice

一般說明

The InnoZyme TACE Activity Kit is a specific and sensitive assay designed to measure human TACE activity in cell lysates and biological samples and for screening enzyme inhibitors. An Anti-Human TACE-Coated 96-Well Plate is pre-coated with a monoclonal antibody specific for human TACE that captures the enzyme. Unbound material is discarded, the plate is washed, and the activity of captured TACE is measured using an internally quenched fluorescent substrate, MCA-KPLGL-Dpa-AR-NH2. Cleavage of the scissile amide bond, G-L, releases the fluorophore from the quenching molecule, Dpa, resulting in an increase in fluorescence. Fluorescence of the cleaved product, MCA-KPLG, is measured at an excitation wavelength of ~324 nm and emission wavelength of ~400 nm. The level of fluorescence is directly related to the enzyme activity.

• Highly specific: based on immunocapture of human TACE
• Highly sensitive and quantitative: assay range 5-100 ng/ml
• Convenient: 96-well format and non-radioactive detection
• Versatile: appropriate for measuring active TACE and high-throughput screening of TACE inhibitors

成分

Anti-Human TACE-Coated 96-Well Plate, Control, Substrate, Sample Buffer, Assay Buffer, Wash Buffer, Plate Sealer, and a user protocol.
anti-human TACE-coated 96-well plate, TACE control, substrate, sample buffer, assay buffer, wash buffer, plate sealer, user protocol

警告

Toxicity: Multiple Toxicity Values, refer to MSDS (O)

原則

The InnoZyme TACE Activity Kit is designed to measure human TACE activity in cell lysates and biological samples. The assay may also be used for screening enzyme inhibitors, but the end-user must supply purified enzyme for this application.

準備報告

All reagents necessary to perform the assay are supplied with the kit. Warm all reagents to room temperature (15-25°C) immediately prior to use.For analyzing biological samples the following reagent preparation is required:• Wash Buffer (1X): Dilute Wash Buffer 1:20 with dH2O . To prepare Wash Buffer (1X) for a single wash step for the entire plate, add 2 ml Wash Buffer to 38 ml dH2O. • Control: Dilute the Control with chilled Sample Buffer. Refer to the vial label for lot-specific dilution information.Important Note: Following initial thaw the Control should be dispensed into aliquots and stored at -70°C. Avoid freeze/thaw cycles.• Substrate (1X): Dilute Substrate 1:200 with Assay Buffer. To prepare Substrate (1X) for the entire plate, add 50 µl Substrate to 9.95 ml Assay Buffer.For inhibitor screening the following additional reagent preparation is required:• Test inhibitor(s): Prepare dilutions of test inhibitors in Assay Buffer as necessary.• Diluted Substrate: Dilute Substrate 1:50 with Assay Buffer. To prepare Substrate for the entire plate add 40 µl Substrate to 1.95 ml Assay Buffer.
Dilute samples as necessary with Sample Buffer.Recommended guidelines for sample preparation:1. Total protein concentration in cell lysates should be >5 mg/ml2. Dilution factor for cell lysates at >5 mg/ml is approximately 1:20 or higher

儲存和穩定性

Upon receipt the unopened kit should be stored at -20°C or -70°C. All kit components, once opened, can be stored for up to 3 months under the following conditions:



Refrigerate (4°C):

Sample Buffer

Assay Buffer

Wash Buffer

Substrate

Anti-Human TACE-coated 96-well plate



Deep Freeze (-70°C):

Control*



*Note: Following initial use the Control should be dispensed into aliquots and stored at -70°C. Avoid freeze/thaw cycles.

分析報告

Positive Control
Human recombinant TACE
The results are displayed in relative fluorescence units (RFU): 1. Correct the fluorescence from each sample and Control by subtracting the fluorescence of the Blank.2. Calculate the mean fluorescence for each sample and Control from duplicate readings to obtain the final RFU.

其他說明

Kirkegaard, T., et al. 2004. Clin. Exp. Immunol.135, 146.
Neumann, U., et al. 2004. Anal. Biochem.328, 166.
Skovronsky, D.M., et al. 2001. J. Neurobiol.49, 40.
Black, R.A., et al. 1997. Nature385, 729.
Moss, M.L., et al. 1997. Nature385, 733.



Selected Citations
DasGupta S., et al. 2009. Bioorg. Med. Chem.17, 3604.


法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

10-13 - German Storage Class 10 to 13


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Harry Bulstrode et al.
Cancer letters, 326(1), 79-87 (2012-07-31)
It has been proposed that gliomas contain a subpopulation of 'Brain Tumor Stem Cells' (BTSCs), which demonstrate resistance to conventional therapies. A potential component of the environment governing the behavior of these BTSCs is a class of transmembrane proteins with
Chang Guan et al.
Oxidative medicine and cellular longevity, 2021, 5572088-5572088 (2021-05-27)
A disintegrin and metalloproteinase 17 (ADAM17) is a transmembrane protein that is widely expressed in various tissues; it mediates the shedding of many membrane-bound molecules, involving cell-cell and cell-matrix interactions. We investigated the role of ADAM17 within mouse cardiac fibroblasts
Yoon Sun Chun et al.
Molecules (Basel, Switzerland), 25(3) (2020-02-08)
Accumulation of β-amyloid (Aβ) in the brain has been implicated in the pathology of Alzheimer's disease (AD). Aβ is produced from the Aβ precursor protein (APP) through the amyloidogenic pathway by β-, and γ-secretase. Alternatively, APP can be cleaved by
Yan Zhang et al.
American journal of physiology. Cell physiology, 317(4), C776-C787 (2019-08-08)
Vulnerable plaques in advanced atherosclerosis have defective efferocytosis. The role of ANG II in the progression of atherosclerosis is not fully understood. Herein, we investigated the effects and the underlying mechanisms of ANG II on macrophage efferocytosis in advanced atherosclerosis.
Elodie J Siney et al.
Molecular neurobiology, 54(5), 3893-3905 (2016-08-20)
Glioblastoma is the most common form of primary malignant brain tumour. These tumours are highly proliferative and infiltrative resulting in a median patient survival of only 14 months from diagnosis. The current treatment regimens are ineffective against the small population of

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门